_:n03a1c41fa4bd47a7aaa3c32891a94f8exb1
<http://schema.org/tickerSymbol>
<https://webdisclosure.com/press-release/medesis-pharma-resultats-encourageants-de-la-premiere-phase-de-lessai-clinique-de-phase-2a-pour-le-traitement-de-la-maladie-dalzheimer-avec-le-nanolithium-TOBetejKI9s>